EANS-Adhoc: november AG / Additional waiver of debts by investors

ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.


Erlangen, April 30, 2009

Today, november AG (ISIN: DE000A0S9N72) in cooperation with one of the investors succeeded in restructuring major debts of the company. After private investors already assumed liabilities before, in 2008 additional credits were granted by the investors for interim financing. With a payment of EUR 250.000 by the november AG debts in the amount of a total of EUR 1,0 mio were cleared off. At the same time, accrued interest was redeemed and waiver of interest in the amount of EUR 30.000 p.a. was granted. This constructive cooperation between company and investors and the major waiver of the investors resulted in further considerable decrease of liabilities of the november AG and constitutes another milestone in the economic stabilization of the november AG.

end of announcement euro adhoc

emitter: november AG c/o Progen Biotechnik GmbH, Maaßstr. 30 D-69123 Heidelberg phone: +49 -(0)6221 8278-0 FAX: +49 -(0)6221 8278-24 mail: info@november.de WWW: http://www.november.de sector: Biotechnology ISIN: DE000A0S9N72 indexes: CDAX, Prime All Share, Technologie All Share stockmarkets: regulated dealing/prime standard: Börse Frankfurt, free trade: Börse Berlin, Börse Stuttgart, Börse Düsseldorf, Börse Hannover, Börse München language: English

Rückfragen & Kontakt:

Dr. Dirk Zurek
Tel.: +49 (0) 6221 8278-0
E-Mail: ir@november.de